Lake Bleu Capital

Portfolio Companies 2026 for Lake Bleu Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Lake Bleu Capital accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $1.9B. The median disclosed raise is $115M, and the largest is MediTrust Health at $463M, ahead of Bang Er Orthopedic ($230M) and RecBio ($227M).

The names that recur most often on these portfolio cap tables are Lake Bleu Capital (14 companies), Legend Capital (4 companies), Vivo Capital (4 companies), Sino Biopharm (3 companies), Invus (3 companies), SymBiosis (3 companies). By latest disclosed round, the market skews Series B (5), Series C (2), Growth (1), IPO (1).

Best funded Lake Bleu Capital companies

  1. MediTrust Health — $463M (latest: Series C)
  2. Bang Er Orthopedic — $230M (latest: Growth)
  3. RecBio — $227M (latest: IPO)
  4. AffaMed Therapeutics — $170M (latest: Series B)
  5. Expedition Therapeutics — $165M (latest: Series A)
  6. MicroPort CardioFlow — $132M (latest: Series C)
  7. Tongxin Medical Equipment — $115M (latest: Series E)
  8. Shenji Bio — $110M (latest: Series B)
  9. Sanegene Bio — $110M (latest: Series B)
  10. Remegen — $100M
  11. Lupeng Pharmaceutical — $59M
  12. HC Scientific — $41M (latest: Series B)
  13. BANGBANG ROBOT — $15M (latest: Series B)
  14. METabolic EXplorer — $7.9M

Lake Bleu Capital — related firms and companies (56)

Lake Bleu Capital profile · All research reports